for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Unichem Laboratories Limited

UNLB.BO

Latest Trade

336.50INR

Change

14.20(+4.41%)

Volume

9,723

Today's Range

316.50

 - 

339.60

52 Week Range

75.10

 - 

339.90

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
322.30
Open
316.50
Volume
9,723
3M AVG Volume
3.15
Today's High
339.60
Today's Low
316.50
52 Week High
339.90
52 Week Low
75.10
Shares Out (MIL)
70.41
Market Cap (MIL)
23,568.32
Forward P/E
--
Dividend (Yield %)
1.19

Latest Developments

More

Unichem Laboratories Gets ANDA Approval For Its Apremilast Tablets From FDA

Unichem Laboratories Gets ANDA Approval From FDA For Zonisamide Capsules

Unichem Laboratories Gets ANDA Nod From USFDA For Celecoxib Capsules

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Unichem Laboratories Limited

Unichem Laboratories Limited is a pharmaceutical company. The Company manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has various pharma products for addressing therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management. It provides a range of metabolic syndrome products for addressing diseases, such as hypertension, obesity, atherogenic dyslipidemia and prothrombosis. Its products address acne, immune mediated skin disorders, hereditary skin diseases and genodermatoses, among others. Its products treat rheumatic and orthopedic ailments. It offers an array of products that include anti-depressant, anti-psychotic, tranquilizer, cerebral activator, anti-platelet and neuropathic pain drugs. It has a range of formulation products for addressing ear-nose-throat (ENT)-related health problems. Its brands include Losar, TG Tor, Olsar, Tolol and Trika.

Industry

Major Drugs

Contact Info

Unichem Bhavan

Off S.V.Road, Prabhat Estate

Jogeshwari (West)

400102

India

+91.22.66888333

https://www.unichemlabs.com/

Executive Leadership

Prakash Amrut Mody

Executive Chairman of the Board, Managing Director

Pradeep Bhandari

Chief Compliance Officer, Company Secretary

Rakesh Parikh

Vice President - Finance, IR Contact Officer

Dilip Kunkolienkar

Additional Whole - Time Director

Prafull Anubhai

Independent Non-Executive Director

Key Stats

Price To Earnings (TTM)
133.78
Price To Sales (TTM)
1.84
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
23.06
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

BRIEF-Unichem Laboratories Ltd Reports March Qtr Loss

* UNICHEM LABORATORIES LTD - RECOMMENDED DIVIDEND OF 4 RUPEESPER SHARE

BRIEF-Unichem Laboratories Reports March Qtr Consol Loss 171.9 Mln Rupees

* UNICHEM LABORATORIES LTD SAYS MARCH QUARTER CONSOL LOSS 171.9 MILLION RUPEES; MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 3.20 BILLION RUPEES Source text for Eikon: Further company coverage:

BRIEF-Unichem Laboratories Gets EIR From FDA For Facility At Roha

* UNICHEM LABORATORIES LTD - GOT EIR FROM FDA ON MAY 13, 2020 FOR ACTIVE PHARMACEUTICAL INGREDIENTS FACILITY AT ROHA Source text : https://bit.ly/3cw12hb Further company coverage:

BRIEF-Unichem Laboratories Says U.S. FDA Inspected Co's Active Pharmaceutical Ingredients Manufacturing Unit At Roha

* UNICHEM LABORATORIES -U.S. FDA CONDUCTED INSPECTION AT CO'S ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING UNIT LOCATED AT ROHA FROM FEB 17- FEB 21 Source text for Eikon: Further company coverage:

BRIEF-Unichem Laboratories Gets ANDA Approval From U.S. FDA For Valsartan Tablets, USP

* SAYS GOT ANDA APPROVAL FROM USFDA FOR VALSARTAN TABLETS, USP

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up